Ironwood Pharmaceuticals | IRWD - 销售收入



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.24
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 732.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 106.51M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


销售 更改 日
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.27B 240M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Moderna USD 389M 289M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Pacira USD 177M 19.87M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.09T 100B 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12